secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adverum Biotechnologies, Inc. (—)
CIK:        0001501756
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291682
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adverum receives Nasdaq deficiency notice for bid price below $1.00
-------------------------------------------------------------------

- Common stock closed below $1.00 for 30 consecutive business days as of Dec. 6, 2023.
- Company has until June 3, 2024 to regain compliance with minimum $1.00 bid price.
- If not compliant, Adverum may seek a 180-day extension or implement a reverse stock split.
- Board has authority from stockholders to effect reverse split at ratios from 1:5 to 1:20 through June 9, 2024.
- No immediate effect on listing; Adverum meets all other Nasdaq Capital Market standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501756/000119312523291682/0001193125-23-291682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501756/000119312523291682/d552828d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer